About cochlear ltd. - CHEOF
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment deals with the treatment pathway for acquired or progressive hearing loss. The Services segment offers sound processor upgrades, accessories, and others. The Acoustic segment is for the bone conduction systems. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.
CHEOF At a Glance
Cochlear Ltd.
1 University Avenue
Sydney, New South Wales (NSW) 2109
| Phone | 61-2-9428-6555 | Revenue | 1.48B | |
| Industry | Medical Specialties | Net Income | 233.81M | |
| Sector | Health Technology | 2024 Sales Growth | 12.488% | |
| Fiscal Year-end | 06 / 2025 | Employees | 5,000 | |
| View SEC Filings |
CHEOF Valuation
| P/E Current | 44.091 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 62.178 |
| Price to Sales Ratio | 9.852 |
| Price to Book Ratio | 11.79 |
| Price to Cash Flow Ratio | 57.221 |
| Enterprise Value to EBITDA | 36.234 |
| Enterprise Value to Sales | 9.73 |
| Total Debt to Enterprise Value | 0.011 |
CHEOF Efficiency
| Revenue/Employee | 295,954.228 |
| Income Per Employee | 46,761.345 |
| Receivables Turnover | 4.414 |
| Total Asset Turnover | 0.835 |
CHEOF Liquidity
| Current Ratio | 2.299 |
| Quick Ratio | 1.679 |
| Cash Ratio | 0.813 |
CHEOF Profitability
| Gross Margin | 75.108 |
| Operating Margin | 23.094 |
| Pretax Margin | 21.495 |
| Net Margin | 15.80 |
| Return on Assets | 13.198 |
| Return on Equity | 19.539 |
| Return on Total Capital | 16.797 |
| Return on Invested Capital | 17.736 |
CHEOF Capital Structure
| Total Debt to Total Equity | 13.241 |
| Total Debt to Total Capital | 11.693 |
| Total Debt to Total Assets | 8.878 |
| Long-Term Debt to Equity | 10.981 |
| Long-Term Debt to Total Capital | 9.697 |